First-in-human data of ALLO-501 and ALLO-647 in relapsed/refractory large B-cell or follicular lymphoma (R/R LBCL/FL): ALPHA study.

Neelapu, SS; Munoz, J; Locke, FL; Miklos, DB; Brown, R; McDevitt, JT; Mardiros, A; Demirhan, E; Konto, C; Tees, MT

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):